Treating-to-target in rheumatology: theory and practice

C Duarte, RJO Ferreira, EJF Santos… - Best Practice & Research …, 2022 - Elsevier
Despite its inclusion in current treatment recommendations, adherence to the treat-to-target
strategy (T2T) is still poor. Among the issues are the definition (s) of target, especially the …

Rheumatoid arthritis management in the APLAR region: Perspectives from an expert panel of rheumatologists, patients and community oriented program for control of …

A Chopra, HY Lin, SV Navarra… - … journal of rheumatic …, 2021 - Wiley Online Library
Rheumatoid arthritis (RA) is a major health burden in Asia Pacific affecting the quality of life
of patients and consuming healthcare resources. According to recent estimates from the …

Treat-to-target in rheumatoid arthritis: a real-world study of the application and impact of treat-to-target within the wider context of patient management, patient …

PC Taylor, B Fautrel, Y Piette, S Romero-Yuste… - RMD open, 2022 - rmdopen.bmj.com
Background While treat-to-target (T2T) is endorsed for the management of rheumatoid
arthritis (RA), data on the degree of implementation in clinical practice are limited. This study …

Treatment satisfaction, patient preferences, and the impact of suboptimal disease control in a large international rheumatoid arthritis cohort: SENSE study

PC Taylor, C Ancuta, O Nagy… - Patient preference …, 2021 - Taylor & Francis
Background Patients' needs and perspectives are important determinants of treatment
success in rheumatoid arthritis (RA). Assessing patients' perspectives can help identify …

[HTML][HTML] Go or no-go for treat-to-target in axial spondyloarthritis?

C Webers, M Been, A van Tubergen - Current Opinion in …, 2023 - journals.lww.com
Despite one negative trial, it is too early to abandon T2T in axSpA. Not only more evidence
from clinical trials but also research on the optimal target and management of all facets of …

[HTML][HTML] Validation and implementation of a patient-reported experience measure for patients with rheumatoid arthritis and spondyloarthritis in the Netherlands

E Beckers, C Webers, A Boonen, PM Ten Klooster… - Clinical …, 2020 - Springer
Objectives To test the psychometric properties of the United Kingdom's Commissioning for
Quality in Rheumatoid Arthritis Patient-Reported Experience Measure (CQRA-PREM) in …

Nuciferine alleviates collagen-induced arthritic in rats by inhibiting the proliferation and invasion of human arthritis-derived fibroblast-like synoviocytes and rectifying …

W Hao, G Xiaolong, AI Fangbin, YU Zhilun… - Chinese Journal of …, 2024 - Elsevier
Rheumatoid arthritis (RA) is a chronic autoimmune disorder marked by persistent synovial
inflammation and joint degradation, posing challenges in the development of effective …

[HTML][HTML] Unlocking the value of anti-TNF biosimilars: reducing disease burden and improving outcomes in chronic immune-mediated inflammatory diseases: a …

MF Rezk, B Pieper - Advances in Therapy, 2020 - Springer
Immune-mediated inflammatory diseases (IMIDs) are chronic conditions that create a
significant disease burden on millions of patients while adding a major financial burden to …

Treat-to-target in axial spondyloarthritis: an observational study in daily practice

E Beckers, A Boonen, C Webers, P Ten Klooster… - …, 2022 - academic.oup.com
Objectives To evaluate the extent to which internationally agreed treat-to-target
recommendations were applied in clinical practice in patients with axial spondyloarthritis …

[HTML][HTML] Immunosensing for Early Detection of Rheumatoid Arthritis Biomarkers: Anti-Cyclic Citrullinated Peptide Antibodies Based on Tilted-Fiber Bragg Grating …

HY Wen, CC Chiang, RY Chen, WZ Ni, YQ Weng… - Bioengineering, 2023 - mdpi.com
Rheumatoid arthritis (RA) is regarded as a chronic, immune-mediated disease that leads to
the damage of various types of immune cells and signal networks, followed by inappropriate …